Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 3/20 | 0.31 |
| ▸ | MGLL | Q99685 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2623759 | 0.94 | MEN1 (0.34) | MEN1KMT2AFAAHMGLLSLC7A5 | |
| SCHEMBL2623758 | 0.90 | CYP17A1 (0.36) | MEN1KMT2AFAAHMGLL | |
| SCHEMBL2623760 | 0.86 | ALDH1A1 (0.39) | MEN1KMT2ANPC1RAB9ACYP2C9 | |
| SCHEMBL2623761 | 0.86 | KDM4C (0.39) | GRM2FAAHMGLLSLC7A5ALDH1A1 | |
| SCHEMBL13053149 | 0.82 | ALDH1A1 (0.39) | MEN1KMT2ACNR1CNR2SLC7A5 | |
| SCHEMBL2623728 | 0.76 | L3MBTL1 (0.37) | MEN1KMT2ACYP2C9ALDH1A1TSHR | |
| SCHEMBL19413370 | 0.74 | ALDH1A1 (0.45) | FAAHMGLLSLC7A5CYP2C9ALDH1A1 | |
| SCHEMBL2300944 | 0.74 | ALDH1A1 (0.45) | FAAHMGLLSLC7A5CYP2C9ALDH1A1 | |
| SCHEMBL14523554 | 0.74 | ALDH1A1 (0.45) | FAAHMGLLSLC7A5CYP2C9ALDH1A1 | |
| SCHEMBL6547015 | 0.74 | CALM1 (0.50) | SLC7A5NPC1RAB9AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120091884-A1 | HEPTAAZAPHENALENE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AT) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120091884-A1 | HEPTAAZAPHENALENE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | HSD17B2, CYP1A2, HSD17B1 | GRM2 2413/4885MEN1 3492/4885KMT2A 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.